Sandu Pharma. — 360° view

Sandu Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹19 crore and net profit of ₹0.79 crore for the September 2026 quarter.

Sandu Pharma. (BSE: SANDUPHQ) closed at ₹35.71 on 20 Nov 2026, down 14.9% over the past year. Its market capitalisation is ₹34 crore and it trades at 16.9 times earnings.

Share price
₹35.71 (20 Nov 2026)
Market cap
₹34 Cr (20 Nov 2026)
P/E
16.91 (20 Nov 2026)
Revenue
₹19 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
6.43% (FY26)
ROE
4.13% (FY26)
Book value
₹45.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹50.00 / ₹30.00 (20 Nov 2026)
1-year return
-14.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: SANDUPHQ

Incorporated in 1985, Sandu Pharmaceuticals Ltd is a manufacturer of Ayurvedic Medicines.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.